R M Pearce|H C Jackson - JoVE Visualize

Showing results (81-90 of 104) with videos related to

Pageof 11

Sort By:

Epilepsy Research|July 1, 1991

Anticonvulsant activity of the imidazoline 6,7-benzoidazoxanH C Jackson, T L Ripley, S L Dickinson, et al.

Journal of Psychopharmacology (Oxford, England)|January 1, 1997

Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfallsE S Robinson, D J Nutt, H C Jackson, et al.

British Journal of Pharmacology|June 1, 1992

The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the ratH C Jackson, I J Griffin, S D Birkett, et al.

The Journal of Infectious Diseases|March 1, 1991

No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis cariniiH C Jackson, D Colthurst, V Hancock, et al.

IEEE Transactions on Medical Imaging|January 1, 1984

Imaging by injection of accelerated radioactive particle beamsJ Llacer, A Chatterjee, E L Alpen, et al.

British Journal of Pharmacology|October 12, 1999

Autoradiographical and behavioural effects of a chronic infusion of antisense to the alpha2D-adrenoceptor in the ratE S Robinson, D J Nutt, L Hall, et al.

British Journal of Pharmacology|August 1, 1997

Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the ratH C Jackson, A M Needham, L J Hutchins, et al.

European Heart Journal|February 13, 2001

RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart diseaseE A Whitsel, T E Raghunathan, R M Pearce, et al.

International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 3, 1998

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramineD J Heal, S Aspley, M R Prow, et al.

Journal of Neurochemistry|June 1, 1994

(S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 miceC Thomsen, H Klitgaard, M Sheardown, et al.

Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:

Pageof 11

Epilepsy Research|July 1, 1991

Anticonvulsant activity of the imidazoline 6,7-benzoidazoxanH C Jackson, T L Ripley, S L Dickinson, et al.

Journal of Psychopharmacology (Oxford, England)|January 1, 1997

Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfallsE S Robinson, D J Nutt, H C Jackson, et al.

British Journal of Pharmacology|June 1, 1992

The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the ratH C Jackson, I J Griffin, S D Birkett, et al.

The Journal of Infectious Diseases|March 1, 1991

No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis cariniiH C Jackson, D Colthurst, V Hancock, et al.

IEEE Transactions on Medical Imaging|January 1, 1984

Imaging by injection of accelerated radioactive particle beamsJ Llacer, A Chatterjee, E L Alpen, et al.

British Journal of Pharmacology|October 12, 1999

Autoradiographical and behavioural effects of a chronic infusion of antisense to the alpha2D-adrenoceptor in the ratE S Robinson, D J Nutt, L Hall, et al.

British Journal of Pharmacology|August 1, 1997

Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the ratH C Jackson, A M Needham, L J Hutchins, et al.

European Heart Journal|February 13, 2001

RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart diseaseE A Whitsel, T E Raghunathan, R M Pearce, et al.

International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 3, 1998

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramineD J Heal, S Aspley, M R Prow, et al.

Journal of Neurochemistry|June 1, 1994

(S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 miceC Thomsen, H Klitgaard, M Sheardown, et al.

Pageof 11